{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:31:02Z","timestamp":1789353062251,"version":"build-2803163510"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.exer.2014.10.002","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T03:46:21Z","timestamp":1412826381000},"page":"161-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Natural product inhibitors of ocular angiogenesis"],"prefix":"10.1016","volume":"129","author":[{"given":"Rania S.","family":"Sulaiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halesha D.","family":"Basavarajappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Corson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2014.10.002_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijc.11010","article-title":"Vascular targeting effect of combretastatin A-4 phosphate dominates the inherent angiogenesis inhibitory activity","volume":"105","author":"Ahmed","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.exer.2014.10.002_bib2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/ICU.0b013e3282f0ca54","article-title":"Anti-vascular endothelial growth factor therapy for ocular neovascular disease","volume":"18","author":"Andreoli","year":"2007","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.exer.2014.10.002_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.38.7.397","article-title":"Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia","volume":"38","author":"Ashton","year":"1954","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.10.002_bib4","doi-asserted-by":"crossref","first-page":"7936","DOI":"10.1158\/0008-5472.CAN-03-3104","article-title":"Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3\u2032-kinase activity","volume":"64","author":"Bagli","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.exer.2014.10.002_bib5","doi-asserted-by":"crossref","first-page":"35501","DOI":"10.1074\/jbc.M302967200","article-title":"Honokiol, a small molecular weight natural product, inhibits angiogenesis in\u00a0vitro and tumor growth in\u00a0vivo","volume":"278","author":"Bai","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.exer.2014.10.002_bib6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chembiol.2007.04.010","article-title":"The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin","volume":"14","author":"Bargagna-Mohan","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.exer.2014.10.002_bib7","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1074\/jbc.M109.093765","article-title":"Withaferin a targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis","volume":"285","author":"Bargagna-Mohan","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.exer.2014.10.002_bib8","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1167\/iovs.05-1452","article-title":"Small molecule anti-angiogenic probes of the ubiquitin proteasome pathway: potential application to choroidal neovascularization","volume":"47","author":"Bargagna-Mohan","year":"2006","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.10.002_bib9","article-title":"Structure-activity relationship studies of a natural product inhibitor of choroidal angiogenesis","volume":"54","author":"Basavarajappa","year":"2013","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.10.002_bib10","article-title":"Identification and characterization of a novel synthetic homoisoflavonoid as an inhibitor of retinal angiogenesis","volume":"55","author":"Basavarajappa","year":"2014","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.10.002_bib11","doi-asserted-by":"crossref","first-page":"e95694","DOI":"10.1371\/journal.pone.0095694","article-title":"Synthesis and mechanistic studies of a novel homoisoflavanone inhibitor of endothelial cell growth","volume":"9","author":"Basavarajappa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2014.10.002_bib12","doi-asserted-by":"crossref","first-page":"e12515","DOI":"10.1371\/journal.pone.0012515","article-title":"Broad spectrum antiangiogenic treatment for ocular neovascular diseases","volume":"5","author":"Benny","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2014.10.002_bib13","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1096\/fj.01-0028fje","article-title":"Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes","volume":"15","author":"Brakenhielm","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.exer.2014.10.002_bib14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2144\/000112812","article-title":"Detection of S-phase cell cycle progression using 5-ethynyl-2\u2032-deoxyuridine incorporation with click chemistry, an alternative to using 5-bromo-2\u2032-deoxyuridine antibodies","volume":"44","author":"Buck","year":"2008","journal-title":"Biotechniques"},{"key":"10.1016\/j.exer.2014.10.002_bib15","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1167\/iovs.10-5524","article-title":"In\u00a0vitro screening for angiostatic potential of herbal chemicals","volume":"51","author":"Cao","year":"2010","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.10.002_bib16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exer.2014.10.002_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00417-007-0728-9","article-title":"Quercetin inhibits choroidal and retinal angiogenesis in\u00a0vitro","volume":"246","author":"Chen","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2014.10.002_bib18","first-page":"281","article-title":"Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention","volume":"103","author":"Coats","year":"2005","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.exer.2014.10.002_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archopht.122.4.477","article-title":"Causes and prevalence of visual impairment among adults in the United States","volume":"122","author":"Congdon","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2014.10.002_bib20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2007.08.021","article-title":"Molecular understanding and modern application of traditional medicines: triumphs and trials","volume":"130","author":"Corson","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.exer.2014.10.002_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.exer.2014.10.002_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archopht.1989.01070010270035","article-title":"A\u00a0new model of experimental choroidal neovascularization in the rat","volume":"107","author":"Dobi","year":"1989","journal-title":"Arch. Ophthalmol."},{"issue":"Suppl.\u00a0l","key":"10.1016\/j.exer.2014.10.002_bib23","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.survophthal.2006.10.017","article-title":"Ocular neovascularization: basic mechanisms and therapeutic advances","volume":"52","author":"Dorrell","year":"2007","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2014.10.002_bib24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.exer.2014.10.002_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease","volume":"1","author":"Folkman","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2014.10.002_bib26","first-page":"89","article-title":"Inhibition of angiogenesis","volume":"3","author":"Folkman","year":"1992","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.exer.2014.10.002_bib27","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0278-6915(95)00077-1","article-title":"Review of the biology of quercetin and related bioflavonoids","volume":"33","author":"Formica","year":"1995","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.exer.2014.10.002_bib28","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1073\/pnas.90.7.2690","article-title":"Genistein, a dietary-derived inhibitor of in\u00a0vitro angiogenesis","volume":"90","author":"Fotsis","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2014.10.002_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.devcel.2009.01.003","article-title":"Regulation of angiogenesis by oxygen and metabolism","volume":"16","author":"Fraisl","year":"2009","journal-title":"Dev. Cell."},{"key":"10.1016\/j.exer.2014.10.002_bib30","first-page":"932","article-title":"Inhibition of immunologically induced inflammation by the plant steroid withaferin A","volume":"23","author":"Fugner","year":"1973","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.exer.2014.10.002_bib31","first-page":"3429","article-title":"Regulation of ornithine decarboxylase induction by deguelin, a natural product cancer chemopreventive agent","volume":"57","author":"Gerhauser","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.exer.2014.10.002_bib32","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0002-9440(10)64930-9","article-title":"Inhibition of proliferative retinopathy by the anti-vascular agent combretastatin-A4","volume":"160","author":"Griggs","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2014.10.002_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7696(08)61873-2","article-title":"NF-\u03baB and Rel: participants in a multiform transcriptional regulatory system","volume":"143","author":"Grilli","year":"1993","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.exer.2014.10.002_bib34","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ajo.2003.09.042","article-title":"Choroidal neovascularization","volume":"137","author":"Grossniklaus","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.10.002_bib35","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.preteyeres.2010.05.003","article-title":"Animal models of choroidal and retinal neovascularization","volume":"29","author":"Grossniklaus","year":"2010","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.exer.2014.10.002_bib36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.survophthal.2009.02.004","article-title":"Bevacizumab (Avastin) for the treatment of ocular disease","volume":"54","author":"Gunther","year":"2009","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2014.10.002_bib37","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1158\/1535-7163.MCT-05-0431","article-title":"The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand","volume":"5","author":"Horinaka","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.exer.2014.10.002_bib38","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1167\/iovs.07-1426","article-title":"Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin","volume":"49","author":"Izumi-Nagai","year":"2008","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.10.002_bib39","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/jn\/136.5.1178","article-title":"Quercetin inhibits eNOS, microtubule polymerization, and mitotic progression in bovine aortic endothelial cells","volume":"136","author":"Jackson","year":"2006","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.exer.2014.10.002_bib40","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1056\/NEJMra0801537","article-title":"Age-related macular degeneration","volume":"358","author":"Jager","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.exer.2014.10.002_bib41","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1542\/peds.91.5.859","article-title":"Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity","volume":"91","author":"Javitt","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.exer.2014.10.002_bib42","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/bjophthalmol-2011-300110","article-title":"Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models","volume":"95","author":"Jhanji","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.10.002_bib43","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/embor.2009.12","article-title":"Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia?","volume":"10","author":"Ji","year":"2009","journal-title":"EMBO Rep."},{"key":"10.1016\/j.exer.2014.10.002_bib44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1423-0127-20-38","article-title":"Animal models of diabetic retinopathy: doors to investigate pathogenesis and potential therapeutics","volume":"20","author":"Jo","year":"2013","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.exer.2014.10.002_bib45","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/carcin\/bgp039","article-title":"Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway","volume":"30","author":"Jung","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.exer.2014.10.002_bib46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/jop.2006.0103","article-title":"Evaluation of the vascular targeting agent combretastatin a-4 prodrug on retinal neovascularization in the galactose-fed dog","volume":"23","author":"Kador","year":"2007","journal-title":"J.\u00a0Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2014.10.002_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jnutbio.2008.10.004","article-title":"Licorice isoliquiritigenin dampens angiogenic activity via inhibition of MAPK-responsive signaling pathways leading to induction of matrix metalloproteinases","volume":"21","author":"Kang","year":"2010","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.exer.2014.10.002_bib48","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1021\/jf990153+","article-title":"Quantitation of flavonoid constituents in citrus fruits","volume":"47","author":"Kawaii","year":"1999","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.exer.2014.10.002_bib49","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrc905","article-title":"Clinical translation of angiogenesis inhibitors","volume":"2","author":"Kerbel","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.exer.2014.10.002_bib50","first-page":"1868","article-title":"Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation","volume":"15","author":"Kim","year":"2009","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2014.10.002_bib51","first-page":"556","article-title":"Inhibition of choroidal neovascularization by homoisoflavanone, a new angiogenesis inhibitor","volume":"14","author":"Kim","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2014.10.002_bib52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1124\/jpet.107.132720","article-title":"Antiangiogenic effect of deguelin on choroidal neovascularization","volume":"324","author":"Kim","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.exer.2014.10.002_bib53","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1111\/j.1582-4934.2008.00243.x","article-title":"Deguelin inhibits retinal neovascularization by down-regulation of HIF-1\u03b1 in oxygen-induced retinopathy","volume":"12","author":"Kim","year":"2008","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.exer.2014.10.002_bib54","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bbrc.2007.08.100","article-title":"Homoisoflavanone inhibits retinal neovascularization through cell cycle arrest with decrease of cdc2 expression","volume":"362","author":"Kim","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2014.10.002_bib55","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jcb.10543","article-title":"Flavonoids inhibit VEGF\/bFGF-induced angiogenesis in\u00a0vitro by inhibiting the matrix-degrading proteases","volume":"89","author":"Kim","year":"2003","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.exer.2014.10.002_bib56","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3341\/kjo.2010.24.2.108","article-title":"Retinal protective effects of resveratrol via modulation of nitric oxide synthase on oxygen-induced retinopathy","volume":"24","author":"Kim","year":"2010","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.10.002_bib57","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1158\/1940-6207.CAPR-08-0184","article-title":"A\u00a0novel derivative of the natural agent deguelin for cancer chemoprevention and therapy","volume":"1","author":"Kim","year":"2008","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.exer.2014.10.002_bib58","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrd1657","article-title":"The evolving role of natural products in drug discovery","volume":"4","author":"Koehn","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.exer.2014.10.002_bib59","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1248\/cpb.16.1139","article-title":"Coumarins from the root of Angelica gigas Nakai","volume":"16","author":"Konoshima","year":"1968","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.exer.2014.10.002_bib60","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0006-2952(94)90060-4","article-title":"Phosphotyrosine inhibition and control of vascular endothelial cell proliferation by genistein","volume":"48","author":"Koroma","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.exer.2014.10.002_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1743-7075-4-8","article-title":"Effects of curcumin on retinal oxidative stress and inflammation in diabetes","volume":"4","author":"Kowluru","year":"2007","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.exer.2014.10.002_bib62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mvr.2013.01.002","article-title":"Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats","volume":"87","author":"Kumar","year":"2013","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.exer.2014.10.002_bib63","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/030089168707300105","article-title":"Turmeric and curcumin as topical agents in cancer therapy","volume":"73","author":"Kuttan","year":"1987","journal-title":"Tumori"},{"key":"10.1016\/j.exer.2014.10.002_bib64","first-page":"3158","article-title":"VEGF is major stimulator in model of choroidal neovascularization","volume":"41","author":"Kwak","year":"2000","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.10.002_bib65","first-page":"106594","article-title":"Animal models of diabetic retinopathy: summary and comparison","volume":"2013","author":"Lai","year":"2013","journal-title":"J.\u00a0Diabetes Res."},{"key":"10.1016\/j.exer.2014.10.002_bib66","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/nprot.2013.135","article-title":"Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice","volume":"8","author":"Lambert","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.exer.2014.10.002_bib67","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1039\/C4OB01604A","article-title":"The first synthesis of the antiangiogenic homoisoflavanone, cremastranone","volume":"12","author":"Lee","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.exer.2014.10.002_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pharmthera.2011.01.010","article-title":"Therapeutic applications of compounds in the Magnolia family","volume":"130","author":"Lee","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.exer.2014.10.002_bib69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1168243","article-title":"Drug discovery and natural products: end of an era or an endless frontier?","volume":"325","author":"Li","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.exer.2014.10.002_bib70","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","article-title":"In\u00a0vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in\u00a0vitro","volume":"2","author":"Liang","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.exer.2014.10.002_bib71","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/mol.64.5.1029","article-title":"Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation","volume":"64","author":"Lin","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.exer.2014.10.002_bib72","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/bjo.2006.113902","article-title":"Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions","volume":"91","author":"Lux","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.10.002_bib73","series-title":"Ophthalmic Drug Delivery Systems 2","author":"Macha","year":"2003"},{"key":"10.1016\/j.exer.2014.10.002_bib74","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1083\/jcb.106.4.1375","article-title":"Phenotypic modulation of endothelial cells by transforming growth factor-\u03b2 depends upon the composition and organization of the extracellular matrix","volume":"106","author":"Madri","year":"1988","journal-title":"J.\u00a0Cell. Biol."},{"key":"10.1016\/j.exer.2014.10.002_bib75","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1211\/jpp.62.08.0001","article-title":"Potential of the bioflavonoids in the prevention\/treatment of ocular disorders","volume":"62","author":"Majumdar","year":"2010","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.exer.2014.10.002_bib76","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","article-title":"Polyphenols: food sources and bioavailability","volume":"79","author":"Manach","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.exer.2014.10.002_bib77","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.exer.2005.12.019","article-title":"Comparative assessment of distribution of blackcurrant anthocyanins in rabbit and rat ocular tissues","volume":"83","author":"Matsumoto","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2014.10.002_bib78","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1021\/jf000892m","article-title":"Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants","volume":"49","author":"Miean","year":"2001","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.exer.2014.10.002_bib79","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/j.ejmech.2011.07.057","article-title":"Natural products: an evolving role in future drug discovery","volume":"46","author":"Mishra","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.exer.2014.10.002_bib80","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/11585520-000000000-00000","article-title":"Cost effectiveness of treatments for wet age-related macular degeneration","volume":"29","author":"Mitchell","year":"2011","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.exer.2014.10.002_bib81","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10456-004-1026-3","article-title":"Withaferin A is a potent inhibitor of angiogenesis","volume":"7","author":"Mohan","year":"2004","journal-title":"Angiogenesis"},{"key":"10.1016\/j.exer.2014.10.002_bib82","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1074\/jbc.275.14.10405","article-title":"Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B","volume":"275","author":"Mohan","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.exer.2014.10.002_bib83","first-page":"2110","article-title":"Normalization of retinal vascular permeability in experimental diabetes with genistein","volume":"42","author":"Nakajima","year":"2001","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.10.002_bib84","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1167\/iovs.02-0985","article-title":"Combretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularization","volume":"44","author":"Nambu","year":"2003","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.10.002_bib85","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1021\/np030096l","article-title":"Natural products as sources of new drugs over the period 1981-2002","volume":"66","author":"Newman","year":"2003","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.exer.2014.10.002_bib86","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrd1955","article-title":"Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease","volume":"5","author":"Ng","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.exer.2014.10.002_bib87","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1158\/0008-5472.CAN-04-2427","article-title":"Endogenous inhibitors of angiogenesis","volume":"65","author":"Nyberg","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.exer.2014.10.002_bib88","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0092-8674(94)90482-0","article-title":"The ubiquitin-proteasome pathway is required for processing the NF-\u03baB1 precursor protein and the activation of NF-\u03baB","volume":"78","author":"Palombella","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.exer.2014.10.002_bib89","first-page":"1901","article-title":"A\u00a0robust model for simultaneously inducing corneal neovascularization and retinal gliosis in the mouse eye","volume":"17","author":"Paranthan","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2014.10.002_bib90","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.1167\/iovs.11-8790","article-title":"Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production","volume":"53","author":"Park","year":"2012","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.10.002_bib91","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1167\/iovs.05-0580","article-title":"Effect of curcumin on proliferation of human retinal endothelial cells under in\u00a0vitro conditions","volume":"47","author":"Premanand","year":"2006","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.10.002_bib92","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12041-009-0068-0","article-title":"Mediators of ocular angiogenesis","volume":"88","author":"Qazi","year":"2009","journal-title":"J.\u00a0Genet."},{"key":"10.1016\/j.exer.2014.10.002_bib93","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.exer.2014.10.002_bib94","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3747\/co.v13i1.77","article-title":"Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1","volume":"13","author":"Sagar","year":"2006","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.exer.2014.10.002_bib95","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3747\/co.v13i3.88","article-title":"Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 2","volume":"13","author":"Sagar","year":"2006","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.exer.2014.10.002_bib96","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1172\/JCI42142","article-title":"Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life","volume":"120","author":"Sapieha","year":"2010","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.exer.2014.10.002_bib97","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nchembio0707-360","article-title":"Revisiting the ancient concept of botanical therapeutics","volume":"3","author":"Schmidt","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.exer.2014.10.002_bib98","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.freeradbiomed.2008.03.014","article-title":"Inhibition of NADPH oxidase-related oxidative stress-triggered signaling by honokiol suppresses high glucose-induced human endothelial cell apoptosis","volume":"44","author":"Sheu","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.exer.2014.10.002_bib99","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2004-815496","article-title":"Anti-angiogenic activity of a homoisoflavanone from Cremastra appendiculata","volume":"70","author":"Shim","year":"2004","journal-title":"Planta Med."},{"key":"10.1016\/j.exer.2014.10.002_bib100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3835(96)04357-1","article-title":"Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell","volume":"107","author":"Singh","year":"1996","journal-title":"Cancer Lett."},{"key":"10.1016\/j.exer.2014.10.002_bib101","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1651-2227.2002.tb00157.x","article-title":"Pathogenesis of retinopathy of prematurity","volume":"91","author":"Smith","year":"2002","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.exer.2014.10.002_bib102","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.10.002_bib103","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0009-9120(96)00155-5","article-title":"Resveratrol: a molecule whose time has come? and gone?","volume":"30","author":"Soleas","year":"1997","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.exer.2014.10.002_bib104","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S1734-1140(12)70948-9","article-title":"Resveratrol improves diabetic retinopathy possibly through oxidative stress - nuclear factor \u03baB - apoptosis pathway","volume":"64","author":"Soufi","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.exer.2014.10.002_bib105","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/jps.23047","article-title":"Intravitreal kinetics of hesperidin, hesperetin, and hesperidin G: effect of dose and physicochemical properties","volume":"101","author":"Srirangam","year":"2012","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.exer.2014.10.002_bib106","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/bjophthalmol-2011-300654","article-title":"Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug","volume":"96","author":"Stewart","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.10.002_bib107","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mayocp.2011.10.001","article-title":"The expanding role of vascular endothelial growth factor inhibitors in ophthalmology","volume":"87","author":"Stewart","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.exer.2014.10.002_bib108","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0002-9440(10)65753-7","article-title":"Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model","volume":"153","author":"Tobe","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2014.10.002_bib109","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbrc.2013.07.118","article-title":"Honokiol inhibits pathological retinal neovascularization in oxygen-induced retinopathy mouse model","volume":"438","author":"Vavilala","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2014.10.002_bib110","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0891-5849(97)00089-0","article-title":"Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation","volume":"23","author":"Vaya","year":"1997","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.exer.2014.10.002_bib111","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/jop.2005.21.107","article-title":"Genistein inhibited retinal neovascularization and expression of vascular endothelial growth factor and hypoxia inducible factor 1\u03b1 in a mouse model of oxygen-induced retinopathy","volume":"21","author":"Wang","year":"2005","journal-title":"J.\u00a0Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2014.10.002_bib112","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3109\/02713683.2013.868908","article-title":"Baicalin attenuates laser-induced choroidal neovascularization","volume":"39","author":"Yang","year":"2014","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2014.10.002_bib113","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mce.2013.04.021","article-title":"Decursin inhibited proliferation and angiogenesis of endothelial cells to suppress diabetic retinopathy via VEGFR2","volume":"378","author":"Yang","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.exer.2014.10.002_bib114","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1517\/13543784.13.9.1171","article-title":"Combretastatin A4 phosphate: background and current clinical status","volume":"13","author":"Young","year":"2004","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.exer.2014.10.002_bib115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/02713680902725962","article-title":"Ocular pharmacokinetics and availability of topically applied baicalein in rabbits","volume":"34","author":"Zhang","year":"2009","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2014.10.002_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2006.09.002","article-title":"Ocular neovascularization: implication of endogenous angiogenic inhibitors and potential therapy","volume":"26","author":"Zhang","year":"2007","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.exer.2014.10.002_bib117","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.2010.1111","article-title":"Prevalence of diabetic retinopathy in the United States, 2005-2008","volume":"304","author":"Zhang","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.exer.2014.10.002_bib118","first-page":"23","article-title":"Effect of quercetin on formation of choroidal neovascularization (CNV) in age-related macular degeneration (AMD)","volume":"26","author":"Zhuang","year":"2011","journal-title":"Eye Sci."},{"key":"10.1016\/j.exer.2014.10.002_bib119","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/jop.2006.22.425","article-title":"Apigenin inhibits laser-induced choroidal neovascularization and regulates endothelial cell function","volume":"22","author":"Zou","year":"2006","journal-title":"J.\u00a0Ocul. Pharmacol. Ther."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483514002668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483514002668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T16:50:47Z","timestamp":1650387047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483514002668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":119,"alternative-id":["S0014483514002668"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2014.10.002","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural product inhibitors of ocular angiogenesis","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2014.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}